Modulation of Gut Microbiome for Obesity and Diabetes Management

Dear Colleagues,

This Special Issue aims to comprehensively explore the multifaceted interplay between the gut microbiome and metabolic disorders, specifically obesity and diabetes. It seeks to consolidate and disseminate cutting-edge research, elucidating the role of the gut microbiota in the pathogenesis and progression of and the potential therapeutic interventions for these prevalent metabolic conditions.

Microbiome dynamics in metabolic disorders: investigating the intricate relationship between the gut microbiome and the development of obesity and diabetes, encompassing microbial composition, diversity, and functional alterations.

Modulation strategies: exploring diverse interventions targeting the gut microbiota, including dietary modifications, probiotics, prebiotics, fecal microbiota transplantation, and their impact on metabolic health.

Mechanistic insights: unraveling the underlying mechanisms and pathways through which gut microbial composition and activity influence obesity and diabetes onset, progression, and potential reversal.

Clinical implications: assessing the translational potential of microbiome-based interventions in clinical settings, evaluating their efficacy, safety, and long-term effects on managing obesity and diabetes.

Future directions: highlighting the gaps in current knowledge, identifying emerging trends, and proposing avenues for further research and innovative therapeutic strategies aimed at harnessing the gut microbiome for effective obesity and diabetes management.

This Special Issue invites original research, reviews, and perspectives from experts in the field, fostering a comprehensive understanding of the gut microbiome’s pivotal role in shaping metabolic health and paving the way for novel therapeutic interventions targeting obesity and diabetes.

Dr. Gurvinder Kaur
Prof. Dr. Jannette M. Dufour
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• microbiome dynamics in metabolic disorders
• modulation strategies
• mechanistic insights
• clinical implications
• future directions